Cargando…

Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in India

BACKGROUND: HIV-infected persons suffering from tuberculosis experience high mortality. No programmatic studies from India have documented the delivery of mortality-reducing interventions, such as cotrimoxazole prophylactic treatment (CPT) and antiretroviral treatment (ART). To guide TB-HIV policy i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raizada, Neeraj, Chauhan, Lakbir Singh, Babu, B. Sai, Thakur, Rahul, Khera, Ajay, Wares, D. Fraser, Sahu, Suvanand, Bachani, D., Rewari, B. B., Dewan, Puneet K.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695556/ https://www.ncbi.nlm.nih.gov/pubmed/19543396 http://dx.doi.org/10.1371/journal.pone.0005999

Ejemplares similares

HIV Seroprevalence among Tuberculosis Patients in India, 2006–2007
por: Raizada, Neeraj, et al.
Publicado: (2008)

Characteristics and Programme-Defined Treatment Outcomes among Childhood Tuberculosis (TB) Patients under the National TB Programme in Delhi
por: Satyanarayana, Srinath, et al.
Publicado: (2010)

Cotrimoxazole prophylaxis and antiretroviral therapy: an observational cohort study in China
por: Cheng, Wei, et al.
Publicado: (2015)

Risk Factors for Treatment Default among Re-Treatment Tuberculosis Patients in India, 2006
por: Jha, Ugra Mohan, et al.
Publicado: (2010)

Ten Years of Surveillance for Invasive Streptococcus pneumoniae during the Era of Antiretroviral Scale-Up and Cotrimoxazole Prophylaxis in Malawi
por: Everett, Dean B., et al.
Publicado: (2011)

A Multi-Site Validation in India of the Line Probe Assay for the Rapid Diagnosis of Multi-Drug Resistant Tuberculosis Directly from Sputum Specimens
por: Raizada, Neeraj, et al.
Publicado: (2014)

Catching the Missing Million: Experiences in Enhancing TB & DR-TB Detection by Providing Upfront Xpert MTB/RIF Testing for People Living with HIV in India
por: Raizada, Neeraj, et al.
Publicado: (2015)

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa*
por: Kasirye, R, et al.
Publicado: (2015)

Cotrimoxazole Prophylaxis and Tuberculosis Risk among People Living with HIV
por: Hoffmann, Christopher J., et al.
Publicado: (2014)

Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial
por: Polyak, Christina S., et al.
Publicado: (2016)

Effects of cotrimoxazole prophylaxis on Talaromyces marneffei infection in HIV/AIDS patients receiving antiretroviral therapy: a retrospective cohort study
por: Jiang, Junjun, et al.
Publicado: (2019)

Tuberculosis Contact Screening and Isoniazid Preventive Therapy in a South Indian District: Operational Issues for Programmatic Consideration
por: Pothukuchi, Madhavi, et al.
Publicado: (2011)

Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV
por: Ku, Stephane Wen‐Wei, et al.
Publicado: (2019)

Will Adoption of the 2010 WHO ART Guidelines for HIV-Infected TB Patients Increase the Demand for ART Services in India?
por: Kumar, Ajay M. V., et al.
Publicado: (2011)

Cotrimoxazole Prophylaxis Specifically Selects for Cotrimoxazole Resistance in Streptococcus mutans and Streptococcus sobrinus with Varied Polymorphisms in the Target Genes folA and folP
por: William, Buwembo, et al.
Publicado: (2012)

Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa
por: Moodley, Dhayendre, et al.
Publicado: (2013)

Enhancing TB Case Detection: Experience in Offering Upfront Xpert MTB/RIF Testing to Pediatric Presumptive TB and DR TB Cases for Early Rapid Diagnosis of Drug Sensitive and Drug Resistant TB
por: Raizada, Neeraj, et al.
Publicado: (2014)

The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB
por: Muniyandi, Malaisamy, et al.
Publicado: (2023)

Metronidazole or Cotrimoxazole Therapy Is Associated with a Decrease in Intestinal Bioavailability of Common Antiretroviral Drugs
por: Dossou-Yovo, Flore, et al.
Publicado: (2014)

Cotrimoxazole Prophylaxis and Risk of Severe Anemia or Severe Neutropenia in HAART-Exposed, HIV-Uninfected Infants
por: Dryden-Peterson, Scott, et al.
Publicado: (2013)

Treatment Outcome and Mortality at One and Half Year Follow-Up of HIV Infected TB Patients Under TB Control Programme in a District of South India
por: Vijay, Sophia, et al.
Publicado: (2011)

Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India
por: Sachdeva, Kuldeep Singh, et al.
Publicado: (2015)

National policy development for cotrimoxazole prophylaxis in Malawi, Uganda and Zambia: the relationship between Context, Evidence and Links
por: Hutchinson, Eleanor, et al.
Publicado: (2011)

Impact of Anti-Retroviral Treatment and Cotrimoxazole Prophylaxis on Helminth Infections in HIV-Infected Patients in Lambaréné, Gabon
por: Janssen, Saskia, et al.
Publicado: (2015)

Cotrimoxazole Prophylaxis Associated With Reduced Anemia Hazard in HIV-Exposed Infants in a Malaria-Endemic Setting
por: Ewing, Alexander, et al.
Publicado: (2017)

Reduced bacterial skin infections in HIV-infected African children randomized to long-term cotrimoxazole prophylaxis
por: Prendergast, Andrew J., et al.
Publicado: (2016)

Cotrimoxazole prophylaxis was associated with enteric commensal bacterial resistance among HIV‐exposed infants in a randomized controlled trial, Botswana
por: Powis, Kathleen M, et al.
Publicado: (2017)

Successful treatment of cerebral toxoplasmosis with cotrimoxazole
por: Patil, Harsha V., et al.
Publicado: (2011)

Cotrimoxazole - optimal dosing in the critically ill
por: Brown, Glen R
Publicado: (2014)

The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis
por: Juma, Dennis W., et al.
Publicado: (2019)

Facilitators and barriers to cotrimoxazole and nevirapine prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe
por: Sibanda, E, et al.
Publicado: (2012)

Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design
por: Anywaine, Zacchaeus, et al.
Publicado: (2015)

Increased malaria parasitaemia among adults living with HIV who have discontinued cotrimoxazole prophylaxis in Kitgum district, Uganda
por: Orishaba, Philip, et al.
Publicado: (2020)

Comparison between Itraconazole and Cotrimoxazole in the Treatment of Paracoccidiodomycosis
por: Cavalcante, Ricardo de Souza, et al.
Publicado: (2014)

Cotrimoxazole: Stevens-Johnson syndrome: case report
Publicado: (2021)

Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study
por: Kasirye, Ronnie P., et al.
Publicado: (2016)

Effect of Antiretroviral Therapy on Neutrophil Oxidative Burst in Children
por: Rehman, Nama Habib Ur, et al.
Publicado: (2022)

Risk Factors Associated with Default among New Smear Positive TB Patients Treated Under DOTS in India
por: Vijay, Sophia, et al.
Publicado: (2010)

Manuscript title: Facilitators and barriers to cotrimoxazole prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe
por: Sibanda, Euphemia L., et al.
Publicado: (2015)

Brief Report: Cessation of Long-Term Cotrimoxazole Prophylaxis in HIV-Infected Children Does Not Alter the Carriage of Antimicrobial Resistance Genes
por: Francis, Freddy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0bb7cujke0sh5i7652dnroghp4